JPRN-UMIN000044071招募中未知
J-REGISTER: Japanese REal-world data for treatment of afatinib (GIotrif) in first-line setting and Subsequent Therapies for patients with advanced EGFR mutation-positive lung adenocarcinoma - Non-interventional study for real-world data of afatinib treatment in first-line setting and of subsequent therapies for patients with advanced EGFR mutation-positive lung adenocarcinoma
ippon Boehringer Ingelheim Co., Ltd.0 个研究点目标入组 1,000 人开始时间: 2021年4月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient will not be included if any of the following criteria are present: 1.Any contraindication to afatinib as specified in the label of Giotrif 2.Patients treated with afatinib within an interventional trial 3.Patients with active brain metastases at start of afatinib treatment* * Patients with non-active brain metastases (asymptomatic state) are eligible.
研究者
相似试验
招募中
不适用
Japan Apheresis RegistryAny Conditions Requiring Therapeutic ApheresisJPRN-UMIN000039498Japanese Society for Apheresis10,000
招募中
不适用
Japanese nationwide registration survey of patients with Fabry disease in CardiologyFabry diseaseJPRN-UMIN000044018Kochi Medical School, Kochi University300
尚未招募
不适用
Japanese registry for survey of in-hospital resuscitation trialJPRN-UMIN000014824Tokyobay UrayasuIchikawa Medical Center2,000
招募中
不适用
Japanese registry of patients treated with endovascular or open repair for ruptured abdominal aortic aneurysmRuptured abdominal aortic aneurysmJPRN-UMIN000031083The Japanese Society for Vascular Surgery2,000
招募中
Unknown
Integrated Clinical and Omics information Registry in Pulmonary HypertensioPulmonary arterial hypertensionJPRN-UMIN000052692ational Hospital Organization Okayama Medical Center1,000